scispace - formally typeset
Search or ask a question

Showing papers by "Roussel Uclaf published in 1975"


Journal ArticleDOI
01 Aug 1975-Steroids
TL;DR: Methyltrienolone (R 1881), 17beta-hydroxy-17alpha-methyl-estra-4,9,11-trien-3-one, a very active androgen, binds specifically to rat prostate cytosol with a higher affinity than androstanolone, and is thus a useful tool for the detection of elusive androgen receptors and for their study in human tumors where interference from plasma contamination has to be circumvented.

207 citations


Journal ArticleDOI
TL;DR: The positive inotropic effect of isoproterenol on the ischaemic myocardium became masked as a negative contribution associated with a concomitant chronotropic effect developed, and it was proposed that a fixed coronary flow rate limited the oxygen delivery to the myocardia as the heart rate rose.

68 citations


Journal ArticleDOI
TL;DR: The primary advantage of running studies in parallel on several receptors resides in the possibility of classifying the anti-hormones according to whether they possess affinity for a given receptor, thus providing a criterion for the selection of highly specific compounds virtually devoid of hormonal side-effects.

58 citations


Journal ArticleDOI
TL;DR: It is suggested that alpha-fetoprotein protects the fetus from the high circulating hormone concentrations present in the pregnant mother.

51 citations




Patent
22 Jan 1975
TL;DR: In this article, the authors considered the problem of selecting acid addition salts having neurosedative properties and their preparation and proposed a method to select acid addition salts with non-toxic, pharmaceutically acceptable acid addition properties.
Abstract: N-[ω-(4'-(3"-indolyl)-piperidino)-alkyl]-benzamides of the formula ##SPC1## Wherein R is selected from the group consisting of hydrogen and alkoxy of 1 to 3 carbon atoms, R1 and R2 are individually selected from the group consisting of hydrogen and alkyl of 1 to 3 carbon atoms, n is 2 or 3, X is selected from the group consisting of hydrogen and alkoxy of 1 to 3 carbon atoms, X1 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine, --NH2 and ##EQU1## and X2 is selected from the group consisting of hydrogen, chlorine and sulfamoyl and their non-toxic, pharmaceutically acceptable acid addition salts having neurosedative properties and their preparation.

31 citations


Journal ArticleDOI
TL;DR: Not only the amplitude but also the speed of LH response are maximal during the afternoon of proestrus and minimal on diestrus I, while the finding of similar changes of pituitary sensitivity to LH-RH under in vitro conditions using pituitaries collected at the same stag-s of the estrous cycle is ascertanied.

28 citations


Journal ArticleDOI
TL;DR: The results show that the initial release of the steroid is rapid and the highest concentration measured was always in the first sample, usually taken on the first or second day after the insertion, after that the concentrations decreased rapidly.

22 citations


Journal ArticleDOI
TL;DR: Diverse psychoactive compounds effectively compete with imipramine for binding to synaptosomal membranes and the order of their activity is correlated with their lipophilicity, and it is suggested that these compounds interact with a lipophilic pocket of low affinity and low specificity.

19 citations


Patent
28 Jul 1975
TL;DR: In this paper, the 3-quinoline carboxamides of the formula SPC1 were selected from the group consisting of halogen, CF3, OCF3 and SCF3 in the 7- or 8-position.
Abstract: Novel 3-quinoline-carboxamides of the formula ##SPC1## Wherein R is selected from the group consisting of halogen, --CF3, --OCF3 and --SCF3 in the 7- or 8-position, R1 is selected from the group consisting of hydrogen and acyl of an aliphatic carboxylic acid of 2 to 4 carbon atoms, R3 is selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms and R2 is selected from the group consisting of thiazloyl, pyridinyl and oxazolyl and their non-toxic, pharmaceutically acceptable acid addition salts having analgesic activity and their preparation and novel intermediates.

Patent
11 Nov 1975
TL;DR: In this paper, the authors disclosed pharmaceutically-active aminoglycosides comprising 4-O-[2',6'-diamino 2',3,6'-tridesoxy α,D-ribohexopyranosyl] 6-O]-3"-methylamino 3",4,6"-trideoxy α and 2-desoxystreptamine of the formula: ##STR1## and the addition salts thereof with mineral acids or organic acids.
Abstract: There are disclosed pharmaceutically-active aminoglycosides comprising 4-O-[2',6'-diamino 2',3',6'-tridesoxy α,D-ribohexopyranosyl] 6-O-[3"-methylamino 3",4",6"-tridesoxy α,D-xylohexopyranosyl] 2-desoxystreptamine of the formula: ##STR1## and the addition salts thereof with mineral acids or organic acids. Also disclosed are methods for preparation of the novel products as well as certain novel intermediate products. There are also disclosed pharmaceutical compositions in which the novel products are the active agents and a method for the treatment of bacteria infections in humans and animals.

Journal ArticleDOI
TL;DR: The effects of beryllium phosphate on the mouse liver could be mediated by synthesis of α-macrofetoprotein and anti-inflammatory substances by the parenchymal cells triggered by the lysosomal enzymes released from the Kupffer cells.

Patent
Dumont C1, Jacques Laurent1
28 Nov 1975
TL;DR: In this article, the authors proposed novel compositions having antidepressive, anti-emetic and anti-Parkinson activities comprising an effective amount of at least one compound selected from the group consisting of 3-(4'-piperidyl)-indoles of the formula ##SPC1## wherein R is selected from a group consisting consisting of hydrogen and alkoxy of 1 to 5 carbon atoms and R 1 and R 2 are individually selected from each of the groups consisting of a non-toxic, pharmaceutically acceptable acid addition salts and a pharmaceutical carrier and
Abstract: Novel compositions having antidepressive, antiemetic and anti-Parkinson activities comprising an effective amount of at least one compound selected from the group consisting of 3-(4'-piperidyl)-indoles of the formula ##SPC1## Wherein R is selected from the group consisting of hydrogen and alkoxy of 1 to 5 carbon atoms and R 1 and R 2 are individually selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts and a pharmaceutical carrier and to a method of treating depressive states and Parkinson disease in warm-blooded animals and humans.

Patent
04 Sep 1975
TL;DR: In this article, a novel thiophene-acetic acid derivatives of the formulae "STR1" and "STR2" have been proposed, in which R is selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms, R1 is chosen from the groups consisting of lower alkyls of 1-4 carbon atoms and hydrogen and R2 is chosen to be substituted with at least one hydroxy group or an oxygen atoms-containing heterocycle.
Abstract: Novel thiophene-acetic acid derivatives of the formulae ##STR1## wherein R is selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms, R1 is selected from the group consisting of lower alkyl of 1 to 4 carbon atoms and hydrogen and R2 is selected from the group consisting of hydrogen, lower alkyl of 1 to 7 carbon atoms and optionally substituted with at least one hydroxy group or an oxygen atoms-containing heterocycle,di-lower alkylamino-lower alkyl, N-heterocyclic alkyl, alkali metals, alkaline earth metals, aluminum and --H,NH (lower alkyl)2 and Ar is selected from the group consisting of phenyl, optionally substituted with at least one member of the group consisting of halogen, trihalogenomethyl, lower alkyl, lower alkoxy and carboxyl, cyclohexyl, thienyl, furyl, tetrahydrofuryl and pyridyl, and in formula II, ArCO is attached to one of the positions α to the sulfur atom, which compounds have analgesic and anti-inflammatory activity and their preparations.

Patent
14 Apr 1975
TL;DR: In this paper, the central nervous system anticonvulsant activity and their preparation is discussed.Racemates and optically active isomers of compound selected from the group consisting of a compound of the formula (R) where R is selected from a group of compounds consisting of hydrogen, lower alkyl, and optionally substituted with a member of the group of hydroxy and halogen, and lower alkenyl, lower alkynyl.
Abstract: Racemates and optically active isomers of a compound selected from the group consisting of a compound of the formula ##STR1## wherein R is selected from the group consisting of hydrogen, lower alkyl optionally substituted with a member of the group consisting of hydroxy and halogen, lower alkenyl, lower alkynyl, --(CH2)n -- COCH3 where n is 0 or 1, ##STR2## wherein X is selected from the group consisting of lower alkyl and optionally substituted phenyl, aralkyl or 7 to 8 carbon atoms, acyl of an organic carboxylic acid of 1 to 6 carbon atoms optionally substituted with ##STR3## where m is an integer from 0 to 6 and X1 is selected from the group consisting of hydrogen and lower alkyl, ##STR4## where p is an integer from 1 to 6 and X1 is as before and ##STR5## wherein X2 is lower alkyl and R1 and R2 are individually selected from the group consisting of hydrogen, halogen, lower alkyl, lower alkoxy, trifluoromethyl and dilower alkylamino and the non-toxic, pharmaceutically acceptable acid addition and quaternary ammonium salts thereof which have a stimulating effect on the central nervous system while possessing at the same time anticonvulsant activity and their preparation.

Patent
23 Oct 1975
TL;DR: In this article, butyric acid derivatives of the formula are selected from the group consisting of hydrogen, halogen, lower alkyl of 1 to 5 carbon atoms, lower alkoxy, trifluoromethoxy and triffluoromethoromethylthio.
Abstract: Novel butyric acid derivatives of the formula ##SPC1## Wherein X, X1, X2 and X3 are individually selected from the group consisting of hydrogen, halogen, lower alkyl of 1 to 5 carbon atoms, lower alkoxy of 1 to 5 carbon atoms, lower alkylthio of 1 to 5 carbon atoms, trifluoromethoxy, trifluoromethylthio, trifluoromethyl, OH and dilower alkylamino of 1 to 5 carbon atoms for each alkyl, R is selected from the group consisting of hydrogen, lower alkyl of 1 to 5 carbon atoms, o-carboxyphenyl, 2,3-dihydroxypropyl and ##EQU1## wherein P and Q are individually lower alkyl of 1 to 5 carbon atoms, Z and X4 are individually selected from the group consisting of hydrogen and lower alkyl of 1 to 5 carbon atoms and Y is selected from the group consisting of hydrogen and --CH and the dotted line indicates the optional presence of a double bond when Y is hydrogen and when R is hydrogen or o-carboxyphenyl, the salts thereof with a non-toxic pharmaceutically acceptable mineral or orgaic base, which compounds have anti-inflammatory and analgesic activity and are substantially devoid of ulcerigenic activity and their preparation and novel intermediates formed therein.

Patent
22 Sep 1975
TL;DR: In this article, the urea derivatives of the formula ##STR1## were individually selected from the group consisting of hydrogen, chlorine, bromine, nitro, trifluoromethyl, lower alkyl of 1 to 6 carbon atoms and lower alkoxy of 1-6 carbon atoms, n is 0 or 1.
Abstract: Novel urea derivatives of the formula ##STR1## wherein R and R1 are individually selected from the group consisting of hydrogen, chlorine, bromine, nitro, trifluoromethyl, lower alkyl of 1 to 6 carbon atoms and lower alkoxy of 1 to 6 carbon atoms, n is 0 or 1, X is selected from the group consisting of lower alkyl of 1 to 6 carbon atoms optionally substituted with halogen and a nitrogen heterocyclic optionally containing 1 or more other heteroatoms, Y is selected from the group consisting of hydrogen, alkyl of 1 to 4 carbon atoms and S--Z wherein Z is a nitrogen heterocyclic optionally containing 1 or more other heteroatoms and the dotted lines indicate that the compound of formula I may contain no oxygen bound to the sulfur atom or may be in sulfoxide or sulfonyl form which are useful as herbicides and thereon preparation.

Patent
18 Mar 1975
TL;DR: In this paper, a novel thiazolcarboxamides of the formula "SPC1" were proposed, where R is selected from the group consisting of alkyl of 1 to 6 carbon atoms and phenyl.
Abstract: Novel thiazolcarboxamides of the formula ##SPC1## Wherein R is selected from the group consisting of alkyl of 1 to 6 carbon atoms and phenyl, R1 is selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms, n is a whole number from 2 to 5 and X and X1 are individually selected from the group consisting of hydrogen, halogen, trifluoromethyl and alkyl, alkoxy and alkylthio of 1 to 4 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having α-adrenolytic activity and their preparation.

Patent
08 Sep 1975
TL;DR: In this paper, a 17α-steroids derivatives optical active isomers or mixtures thereof of the formula "SPC1" are defined, where each derivatives is selected from the group consisting of hydrogen and methyl, R1 is an alkyl of 1 to 4 carbon atoms, Z is a α-configuration; R2 is an α-alkyl with 1 or 2 double bonds in the 1(2) position when R is methyl and Z is hydrogen.
Abstract: Novel (17α)-steroids derivatives optical active isomers or mixtures thereof of the formula ##SPC1## Wherein R is selected from the group consisting of hydrogen and methyl, R1 is alkyl of 1 to 4 carbon atoms, Z is selected from the group consisting of hydrogen and ##EQU1## of α-configuration; R2 is alkyl of 1 to 4 carbon atoms, the dotted lines in the A and B rings represent optional 1 or 2 double bonds in the 1(2) position when R is methyl and in the 6(7) position when Z is hydrogen and X and Y together form the group ##EQU2## and when X is OH, Y is ##EQU3## and M is selected from the group consisting of hydrogen, --NH4 and alkali metals which have antialdosteronic activity and their preparation.

Patent
07 Nov 1975
TL;DR: In this article, the benzophenone derivatives of the formula "STR1" were individually selected from the group consisting of hydrogen, halogen, alkyl of 1 to 5 carbon atoms, alkoxy of 1-5 carbon atoms.
Abstract: Novel benzophenone derivatives of the formula ##STR1## wherein X and X 1 are individually selected from the group consisting of hydrogen, halogen, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkylthio of 1 to 5 carbon atoms, CF 3 O--, CF 3 S-- and CF 3 --, R is selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms and R 1 is an aliphatic hydrocarbon of the formula --(CH 2 ) a --CH = CH--(CH 2 ) b --H or --(CH 2 ) a --CH 2 --CH 2 --(CH 2 ) b --H where a and b are whole numbers between 0 and 16 and whose sum is not greater than 16 which have a very clear analgesic activity.


Patent
02 Jul 1975
TL;DR: In this paper, the authors proposed a new haptenes of the formula (SPC1) where the haptene is selected from the group of p-phenylene and =N--O--(CH 2 ) c --COOH.
Abstract: Novel haptenes of the formula ##SPC1## Wherein X is ##EQU1## when Y is ##EQU2## in the α- or β-position and R' is selected from the group of p-phenylene and --(CH 2 ) a --and a is a whole number from 1 to 18 with the proviso that a is other than 2 when Y is in the α-position and when Y is hydrogen, X is selected from the group consisting of ##EQU3## and =N--O--(CH 2 ) c --COOH, b is a whole number from 1 to 18 and c is a whole number from 1 to 12 useful for the preparation of antigens formed therefrom.

Patent
10 Jun 1975
TL;DR: In this article, the active principle is 3-(3',4'-dichlorophenyl)-5,5-dimethyl-oxazolidine-2,4-dione of the formula ##STR1##.
Abstract: Antiandrogenic compositions wherein the active principle is 3-(3',4'-dichlorophenyl)-5,5-dimethyl-oxazolidine-2,4-dione of the formula ##STR1## are useful for inducing antiandrogenic activity in warm-blooded animals.

Patent
13 Jan 1975
TL;DR: In this article, the 3-phosphoryloxy-isothiazoles of the formula (SPC1) were selected from the group consisting of alkyl of 1 to 3 carbon atoms, alkoxy of 2 to 4 carbon atoms and NHR'", and R'" is selected from a group consisting consisting of hydrogen and aryl of 6 to 10 carbon atoms.
Abstract: Novel 3-phosphoryloxy-isothiazoles of the formula ##SPC1## Wherein R is selected from the group consisting of alkyl of 1 to 3 carbon atoms, alkoxy of 1 to 3 carbon atoms and ##EQU1## R' and R" being individually SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND ALKYL OF 1 TO 3 CARBON ATOMS, R1 is alkyl of 1 to 3 carbon atoms, R2 is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms, aryl of 6 to 10 carbon atoms, aralkyl of 7 to 12 carbon atoms, cyano, carbalkoxy of 2 to 4 carbon atoms and NHR'", and R'" is selected from the group consisting of hydrogen and aryl of 6 to 10 carbon atoms, R3 is selected from the group consisting of cyano, alkylthio of 1 to 4 carbon atoms, alkylsulfinyl of 1 to 4 carbon atoms, alkylsulfonyl of 1 to 4 carbon atoms, carbamoyl, carbalkoxy of 2 to 4 carbon atoms and ##EQU2## A and B are individually selected from the group consisting of hydrogen and alkyl of 1 to 3 carbon atoms and X is selected from the group consisting of oxygen and sulfur which have excellent insecticidal properties.

Patent
25 Mar 1975
TL;DR: In this article, the authors proposed novel intermediates useful for organic synthesis which are immonium salts of the formula WHEREIN R and R1 are individually selected from the group consisting of lower alkyl, phenyl optionally substituted with halogen and benzyl and taken together are selected from a group which consists of -CH2-CH2 -O-CH 2 -CH 2 CH 2 O-CH O- CH 2 CH2 - and WHERE R4 is alkyls of 1 to 5 carbon atoms.
Abstract: Novel intermediates useful for organic synthesis which are immonium salts of the formula WHEREIN R and R1 are individually selected from the group consisting of lower alkyl, phenyl optionally substituted with halogen and benzyl and taken together are selected from the group consisting of lower alkylene, -CH2-CH2-O-CH2-CH2- and WHERE R4 is alkyl of 1 to 5 carbon atoms, R2 and R3 are individually selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms and phenyl and taken together are selected from the group consisting of alkylene of 3 to 5 carbon atoms and benzoalkylene of 7 to 10 carbon atoms, X is halogen and Y is selected from the group consisting of dilower alkylamino wherein the alkyl have 1 to 5 carbon atoms, morpholino, piperidino and 1-pyrrolidinyl.

Patent
21 Jan 1975
TL;DR: In this article, the preparation of derivatives of 1,2,3,4-tetrahydro-9H-pyrido [3, 4-b] indole is described.
Abstract: The preparation of derivatives of 1,2,3,4-tetrahydro-9H-pyrido [3,4-b] indole is described. In particular the preparation of acrylic esters of beta -(3'-hydroxypropyl)-1,2,3,4-tetrahydro-9H-pyrido [3,4-b] indole is shown to proceed from the oxidation of a 2-alkyloxy-3-hydroxytetrahydropyran to its 2-alkyloxy-3-oxotetrahydropyran derivative. The Wittig condensation is used to effect the reaction of this ketone with a phosphonoacetic ester giving rise to the carbalkoxy methylenic-substitution product, 2-alkyloxy-3-(1'-alkoxycarbonyl)methylidenetetrahydropyran. After acid hydrolysis of the 2-alkyloxy group, condensation is carried out with tryptamine resulting in the desired indole derivatives. Such compounds can be used in the facile preparation of alkaloids of the eburnamonie family.

Patent
24 Sep 1975
TL;DR: Novel crotonanilides of the formula ##STR1## wherein R' is selected from the group consisting of ##STR2## R and R 1 are alkyl of 1 to 6 carbon atoms and R 2 is selected among the groups consisting of hydrogen, methyl and methoxy having pre-and post-emergence herbicidal activity as mentioned in this paper.
Abstract: Novel crotonanilides of the formula ##STR1## wherein R' is selected from the group consisting of ##STR2## R and R 1 are alkyl of 1 to 6 carbon atoms and R 2 is selected from the group consisting of hydrogen, methyl and methoxy having pre- and post-emergence herbicidal activity.


Patent
01 Jul 1975
TL;DR: In this paper, the xanthone-2-carboxylic acid compounds of the formula "STR1" were selected from the group consisting of --COOR', a 1H-tetrazol-5-yl and a 1 H-tetrabrazolylcarbamoyl, R' is selected from a group consisting consisting of hydrogen, alkyl of 1 to 5 carbon atoms and cation of a non-toxic, pharmaceutically acceptable organic or inorganic base.
Abstract: Novel xanthone-2-carboxylic acid compounds of the formula ##STR1## wherein A is selected from the group consisting of --COOR', a 1H-tetrazol-5-yl and a 1H-tetrazolylcarbamoyl, R' is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms and cation of a non-toxic, pharmaceutically acceptable organic or inorganic base, R is selected from the group consisting of hydrogen, alkyl of 1 to 9 carbon atoms, alkoxy of 1 to 9 carbon atoms and alkoxy alkoxy of 2 to 9 carbon atoms and X is selected from the group consisting of ##STR2## AND ##STR3## WHEREIN R1 is alkyl of 1 to 5 carbon atoms, R2 is selected from the group consisting of hydrogen, acyl of an aliphatic acid of 1 to 5 carbon atoms, aroyl of 7 to 8 carbon atoms, araliphatic acyl with 1 to 5 carbon atoms in the aliphatic portion and 6 or 7 carbon atoms in the aryl portion, aralkyl of 7 to 8 carbon atoms, arylsulfonyl, a carbamoyl, a carboxyalkyl of 1 to 5 carbon atoms, --CO--(CH2)n -- Het where n is 1, 2 or 3 and Het is a N-attached nitrogen heterocyclic which may contain an additional heteroatom and ##STR4## AND Alk is alkyl of 1 to 5 carbon atoms and R3 is arylsulfonyl which possess anti-allergic properties and their preparation.